<DOC>
	<DOC>NCT01760616</DOC>
	<brief_summary>To evaluate the efficacy and safety of Huaier Granule for prevention of disease progression of hepatocarcinoma after non-radical hepatectomy.</brief_summary>
	<brief_title>Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy</brief_title>
	<detailed_description>A Prospective, Multicenter, Open-labeled, Parallel -controlled Clinical Study, to evaluate the efficacy and safety of Huaier Granule for prevention of disease progression of hepatocarcinoma after non-radical hepatectomy.</detailed_description>
	<mesh_term>Disease Progression</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<criteria>1. Age: ≥ 18 and ≤ 75 years, both male and female; 2. Nonradical hepatectomy has been performed for hepatocellular carcinoma; 3. The hepatocellular carcinoma has been confirmed by pathological examination; 4. The liver and kidney function satisfies the following conditions within 15 days after surgery (excluding day 15): aspartate aminotransferase(AST), glutamicoxalacetic transaminase(ALT)&lt;3 upper limit of normal(ULN), total bilirubin ≤2 ULN, serum creatinine &lt;1.5 ULN; 5. Other laboratory tests meet the following requirements within 15 days after surgery (excluding day 15): Hb≥9g/dl, platelet count≥60×109/L, neutrophil count&gt; 2.5×109/L; 6. The expected survival time ≥12 weeks; 7. The subjects volunteer to sign the informed consent. 1. Nonhepatocellular carcinoma patients; 2. Those who received radical hepatectomy; 3. Those with hepatic decompensation; 4. Pregnant or lactating women; 5. Those with HIV infection or AIDSassociated diseases; 6. Those with severe acute and chronic diseases, such as infection, diabetes cardiac insufficiency, pulmonary insufficiency, renal insufficiency; 7. Those who can not take drugs by oral route; or those develop serious adverse drug reaction; 8. Drug abusers or those with psychological or mental diseases that may interfere with study compliance; 9. Conditions that are considered not suitable for this study investigators.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Huaier Granule;</keyword>
	<keyword>After non-radical hepatectomy;</keyword>
	<keyword>Prevention of Disease Progression of Hepatocarcinoma;</keyword>
	<keyword>Safety.</keyword>
</DOC>